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Abstract: This paper reports a 17-year seroepidemiological surveillance study of  
Borrelia burgdorferi infection, performed with the aim of improving our knowledge of  
the epidemiology of this pathogen. Serum samples (1,179) from patients (623, stratified 
with respect to age, sex, season, area of residence and occupation) bitten by ticks in two 
regions of northern Spain were IFA-tested for B. burgdorferi antibodies. Positive results 
were confirmed by western blotting. Antibodies specific for B. burgdorferi were found in 
13.3% of the patients; 7.8% were IgM positive, 9.6% were IgG positive, and 4.33% were 
both IgM and IgG positive. Five species of ticks were identified in the seropositive 
patients: Dermacentor marginatus (41.17% of such patients) Dermacentor reticulatus 
(11.76%), Rhiphicephalus sanguineus (17.64%), Rhiphicephalus turanicus (5.88%) and 
Ixodes ricinus (23.52%). B. burgdorferi DNA was sought by PCR in ticks when available. 
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One tick, a D. reticulatus male, was found carrying the pathogen. The seroprevalence 
found was similar to the previously demonstrated in similar studies in Spain and other 
European countries. 
Keywords: Lyme disease; epidemiology; public health 
 
1. Introduction 
Arthropod-borne diseases are the most common zoonoses involving wildlife in the northern 
hemisphere, especially the Old World [1]. Borrelia burgdorferi, the causal agent of Lyme borreliosis 
(LB), is found worldwide and comprises at least 18 genospecies [2,3]. Discovered in 1982,  
B. burgdorferi is now considered an emerging (and possibly under-reported) pathogen that could 
become an important public health problem [4]. Ixodes ricinus is the tick that usually transmits this 
pathogen to humans in Europe [5]. 
In recent years there has been a substantial increase in interest in B. burgdorferi infection, and 
different epidemiological studies have been made in different parts of Spain [6–9]. Clinical cases have 
also been reported [10–13]. Thus far, the prevalence of LB has been studied in high-risk groups, in  
the general population, and in patients showing possible signs of infection [12,14–17]. Ongoing studies 
at the local level are required to construct more efficient risk prediction models. In response to this 
need the present work reports a 17-year epidemiological surveillance study of B. burgdorferi infection 
in two areas of northern Spain where this pathogen is known to exist. 
2. Material and Methods 
2.1. Study Area 
This study was performed in the Province of Palencia (central coordinates 42°00'23" N, 4°31'45" W, 
mean altitude 749 m) and in a small area in the Province of Burgos (central coordinates 42º20'57.1" N, 
3°41'4.7" W, mean altitude 856 m). The mean daily summer temperature in these areas is 36.2 °C, 
while the mean winter temperature is 7.5 °C. Both areas are mainly rural, but recreational activities 
have attracted non-residents to them in recent years. Animal husbandry is economically important in 
both areas, where the parasitisation of livestock by ticks is common. Both areas provide the conditions 
under which LB infections usually occur. 
2.2. Serum Samples 
Serum samples were collected from patients bitten by ticks - and therefore at risk of B. burgdorferi 
infection—over a 17-year period (May1996–May 2013). A total number of 1,179 serum samples from 
623 patients (age range 3 months to 91 years) were available: 601 from the Palencia and 22 from  
the Burgos study areas. By sex 345 (55.3%) of these samples came from males and 278 from females 
(44.7%). All sera were collected from patients at primary healthcare centres. Blood was taken once (at 
first presentation) from 225 patients (36.1%), twice (at first presentation and 30 days later) from  
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240 patients (38.5%), and three times (at first presentation, 30 days later, and at 90 days) from  
158 patients (25.3%). All serum samples were maintained at −20 °C until analysis. The following 
information was collected from all patients: age, sex, occupation, place of residence, symptomatology, 
contact with cattle, profession, and information regarding their tick bite. 
All the patients gave their informed consent to be included in the study (all adult participants and 
from the parents or legal guardians of minors), in compliance with the ethical standards of the Human 
Experimentation Committee of the University of Alcalá de Henares and the Helsinki Declaration of 
1964 (as revised in 2004). All patients that came to a health centre with fever were treated  
with antibiotics. 
2.3. Immunofluorescence 
Sera were tested for B. burgdorferi antibodies by a home-made indirect immunofluorescence assay 
(IFA). The Borrelia employed as the antigen was B. burgdorferi sensu stricto (strain B31 ATCC 
35210). These bacteria were propagated in Barbour Kelly medium and fixed on spot slides.  
The fluorescein-labelled conjugates used were rabbit anti-human IgG and IgM (Sigma, St Louis, MO, 
USA), diluted 1/128 in PBS. Briefly, two-fold dilutions of each serum sample were added to  
the antigen spots and incubated in a humidity chamber for 30 min at 37 °C. After washing,  
the conjugate was added to each sample. The slides were then incubated for 30 min, washed, and 
examined using a BH2 fluorescence microscope (10 × 40, Olympus, Tokyo, Japan). Positive and 
negative control sera were also examined. Sera showing a typical pattern of fluorescence at IgG titres 
of ≥1:256 and IgM titres of ≥1:32 were deemed positive (Figure 1). All positives sera were tested for 
infection by Treponema pallidum by the haemagglutination test (TPHA-BioMérieux, Marcy l E´toile, 
France) to rule out syphilis. 
Figure 1. Typical pattern of B. burgdorferi IFA. (A) Positive sera; (B) Uncertain sera;  
(C) Negative control. 
 
2.4. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis and Western Blotting 
All sera with an uncertain or positive IFA result were subjected to a home-made western blotting 
(WB) test. WB strips were prepared with sonicated B. burgdorferi (strain B31 ATCC 35210)  
cells [18]. Electrophoresis was performed at 125 V for 90 min and the separated proteins transferred to 
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PDVF membranes. These membranes were then cut into strips, hydrated with methanol, and blocked 
with 5% gelatin (Bio-Rad, Hercules, CA, USA). Human serum, diluted 1:200 in TTBS 1%  
(Tris-NaCl, 1% gelatin, 0.05% Tween-20), was then added and incubated at 37 °C/h for 2 h.  
The positive controls used included at least three different monoclonal antibodies (diluted 1:000) from 
the following list: 11G1 (OspA), CB312 (P72), CB2 (OspB), CB1 (Flagelina) (kindly provided by  
Dr. Pedro Anda, Centro Nacional de Microbiología, Majadahonda, Madrid), 181.1 (93 kDa), H9724  
(Fla, 41 kDa) and 84C (OspB, 34 kDa). A human serum positive for B. burgdorferi (supplied by  
Dr. Sofia Nuncio, Centro de Estudos de Vetores e Doenças Infecciosas (CEVDI), Instituto Nacional de 
Saúde, Aguas de Moura, Portugal), diluted 1:200, was used as a further positive control. A human serum 
negative for the bacterium, also diluted 1:200, was used as a negative control, and a strip with PBS as 
white control. After washing with TTBS 0.01% (TBS, 0.1% gelatine, 0.05% Tween-20) alkaline  
phosphatase-conjugated goat anti-human IgG, anti-human IgM or total IgG anti-mouse (Sigma) 
antibodies were added and the preparations incubated and washed as described above. Blots were 
visualized using nitroblue tetrazolium and 5-bromo-4-chloro-3-indoyl-phosphate (Sigma). Serum 
specimens were deemed positive if they reacted with at least five of the following IgG diagnostic 
bands: 18 kDa, 23 kDa (Ospc), 28 kDa, 30 kDa, 39 kDa (BmpA), 41 kDa, 25 kDa, 58 kDa (not 
GroEL), 66 kDa or 93 kDa, and at least two of the following IgM diagnostic bands: 23 kDa (OspC),  
39 kDa (BMPa) or 41 kDA (Fla) (CDC Recommendations, 1995) (Figure 2). 
Figure 2. Western blotting of B. burgdorferi. A: MAb CB312 ; B: MAb H9724 ; C: MAb 
84C; D and E: Sera positive patient for IgM (second and third samples respectively);  
F: Positive control; G: Negative control; H: white control (PBS); MW: molecular weight 
(BioRad). 
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2.5. Analysis of Ticks for Borrelia burgdorferi DNA 
Ticks, collected from the patients whenever possible, were decontaminated by sequential washing 
in 45% alcohol, 30% alcohol, and ultrapure water. Each tick was then transferred to an individual glass 
vessel in which it was cut into pieces using a sterile blade, and DNA extracted in 500 mL of 5% 
Chelex-100 (Bio-Rad, Hercules, CA, USA) [19]. B. burgdorferi DNA was sought by amplification of 
the 5S–23S rRNA intergenic spacer [20]. To prevent DNA contamination and the carryover of 
amplified products, sterile tools were used at all times, and each step of the analysis (extracting DNA, 
preparing the reaction mixture, and amplifying and analysing the PCR product) was performed in  
a separate work area. Two negative controls (Milli-Q water and DNA from laboratory-reared,  
non-infected ticks), and two positive controls (DNA from B. burgdorferi strain Esp-1) were included 
in all PCR runs. 
2.6. Statistical Analysis 
Differences in epidemiological results were compared using the χ2 test (performed manually). 
Significance was set at p < 0.05. 
3. Results 
Specific B. burgdorferi antibodies were detected in 83 (13.3%) patients (Figure 3); 43 males (12.46%) 
and 40 females (14.38%). 
Figure 3. Distribution of seroprevalence by years. 
 
Seven positive sera came from people who lived in the Burgos region (31.8%) and 76 from people 
in the Province of Palencia (12.6%). All seropositive patients had contact with animals, and all age 
groups were represented (range 3–87 years). Table 1 shows there were no significant differences among 
age groups in terms of seropositivity. 
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Table 1. Seroprevalence in relation to age groups. 
Age groups Number (%) 
0–10 years 8 (9.2) 
11–20 years 10 (17.2) 
21–30 years 5 (11.3) 
31–40 years 14 (15.38) 
41–50 years 19 (16.9) 
51–60 years 7 (8.1) 
61–70 years 10 (13.7) 
71–80 years 8 (13.8) 
81–90 years 2 (15.38) 
91–more years ND 
ND: No done. 
Table 2 shows there were no differences in seroprevalence in terms of patient occupation. No 
relationship was seen between seropositivity and province of residence. Most patients had been bitten 
in spring (315 people [50.56%]) or autumn (119 people [21.18%]). 
Table 2. Seroprevalence in terms of patient occupation. 
Patients occupation Number (%) 
Farmer 5 (7.9) 
Livestock 3 (9.6) 
Pastors 1 (7.7) 
Construction workers 6 (25) 
Administrative workers (clerks, lawyers, business) 4 (14.2) 
Service sector (shopkeepers, waiters, cooks, mechanics, maintenance) 8 (25) 
Veterinarians 1 (33.3) 
Health (doctors and nurses) 2 (20%) 
Houesewives 13 (12.6) 
Retirees 10 (14.3) 
Students 5 (7.35) 
Unspecified profession (mostly children under five years) 25 (18.38) 
After examining all patient sera, i.e., including sera taken from patients up to three times, 49 (7.8%) 
were found to be IgM positive and 60 (9.6%) IgG positive; 27 patients (4.33%) had both IgM and IgG 
antibodies (Table 3 shows the distribution by years). 
In those patients for whom more than one serum sample was available (n = 498), 8 (1.61%) showed 
rising IgG titres, five showed rising IgM titres (1.00%), and 4 (0.80%) showed increases in both IgG 
and IgM. Retro-seroconversion with respect to IgG occurred in six people (1.20%), and with respect to 
IgM in one person (0.20%). In both cases, seroconversion and retroconversion, occurred during the 
first years of the study, in particular between 1997 and 2004. Some patients remained completely 
asymptomatic while others showed influenza-like symptoms (fever, fatigue, headaches and joint pain). 
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Table 3. Seroprevalence in relation to years. 
Years Ig G prevalence (%) IgM prevalence (%) IgG+IgM prevalence (%) 
1996 18.18 27.27 9.09 
1997 15.55 35.55 15.55 
1998 2.56 23.07 2.56 
1999 20 13.33 6.66 
2000 9.67 6.45 6.45 
2001 15 10 10 
2002 16.66 16.66 16.66 
2003 13.79 3.44 3.44 
2004 26.47 14.7 14.7 
2005 10 6.66 3.33 
2006 10.71 0 0 
2007 7.14 0 0 
2008 5.26 1.74 1.74 
2009 0 0 0 
2010 9.3 2.32 2.32 
2011 6.89 3.44 1.74 
2012 7.89 0 0 
2013 4.54 0 0 
Five species of ticks (17 ticks) were identified to have bitten the seropositive patients: Dermacentor 
marginatus (41.5%; 14.2% males and 85.71% females), Dermacentor reticulatus (11.76%; 50% males 
and 50% females), Rhiphicephalus sanguineus (17.64%; 66.6% males and 33.3% females), 
Rhiphicephalus turanicus (5.88%; 100% males) and I. ricinus (23.52%; 25% males and 75% females). 
IgM antibodies expressed against B. burgdorferi were found in four patients who had been bitten by  
D. marginatus, in two patients bitten by D. reticulatus, in two patients bitten by R. sanguineus, and in  
one bitten by I. ricinus. A male of D. reticulatus was infected with B. burgdorferi. The tick was 
removed from the scalp of a 13-year-old woman in May 1997. The patient presented a week after the 
bite the presence of regional lymph nodes close to the area of the bite without fever. The patient had 
high titer of IgM and IgG antibodies against B. burgdorferi, but not seroconversion. 
4. Discussion and Conclusions 
Though Lyme disease is thought to have been present in Spain since 1977, its existence was not 
serologically confirmed until 1987 [10,21,22]. Since then, B. burgdorferi infections have been 
frequently recorded, with differences in prevalence from area to area, and its geographical distribution 
may be increasing as a result of climate change, changes in land uses, and evolving socioeconomic 
factors [10,23]. The present work is the longest-term (17 years) epidemiological surveillance study of 
B. burgdorferi ever performed in Spain. The seroprevalence of 13.3% detected in the present work 
falls within the range previously reported for Spain (0.3–14.8%) and other European countries  
(1.8%–19.68%) [24–29]. 
Ticks are abundant in rural areas, and it is reported that those persons whose work implied contact 
with animals in the rural setting are at higher risk of infection [30–33]. However, the prevalence of  
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B. burgdorferi infection in high risk populations is not well known and seems to vary widely from area 
to area. In the present study, no significant differences in seroprevalence were seen between different 
occupation groups and by age, but others authors report studies that shown significant differences in 
seroprevalence data respect to occupation and/or age [32,34]. In the present work, similar seropositivity 
results were seen in different seasons, suggesting that bites can occur throughout the year. 
B. burgdorferi antibodies are developed relatively late in some patients, and indeed never in others. 
However, since several serum samples were available from some patients, a few cases of acute 
(subclinical or clinical) infection (presence of IgM and rising or falling IgG antibody titres) were 
clearly identified. The small number detected may be explained in that all patients presenting with 
fever symptoms were treated with antibiotics in accordance with the policy for the prevention and 
control of tick-borne diseases designed by the Servicio Territorial de Sanidad y Bienestar Social de la 
Junta de Castilla y León (the regional health service). Thus the true number of infections might have 
been masked by this early treatment [35]. Indeed, some authors have now clearly indicated that  
the early administration of antibiotics can postpone or inhibit the development of a response to  
the pathogen [36,37]. The present results may support these findings. Though some authors indicate 
that prophylactic antibiotic treatment should be administered after a tick bite others suggest it is not 
indicated given the low incidence of eventual disease [13,38,39]. Nevertheless, since the transmission 
of B. burgdorferi never occurs within the first 24 h of tick attachment (indeed, 48 h may be required), 
removing ticks as soon as possible is a good prevention method. Sometimes bites from several ticks 
are needed before antibodies to B. burgdorferi become detectable. 
In Europe, B. burgdorferi is usually transmitted to humans via the tick I. ricinus, and mainly by its 
nymphs [2,3,40–43]. These are more active from spring to autumn and need 85% humidity in order to 
thrive. Tick species other than I. ricinus were, however, identified on the patients in the present work, 
including D. marginatus, D. reticulatus, R. sanguineus and R. turanicus. 
PCR detected B. burgdorferi DNA in D. reticulatus males. Dermacentor spp. play an important role 
in the transmission of tick-borne pathogens that is not well recognized in Europe [44,45]. The latter 
authors reported the first epidemiological characterizations of pathogens spread via Dermacentor spp. 
in France. In the present work, B. burgdorferi DNA was detected in a D. reticulatus male. Other 
authors suggest D. reticulatus to have expanded its area of distribution [46]. Certainly, its growing 
presence in Serbia was reported [47]. Further experiments are needed to determine to the vector 
competency of this pathogen. 
In summary, it is important to increase awareness of B. burgdorferi infection, and that better 
surveillance should be implemented. Further studies are planned, including studies using more 
antigens (like other serotypes and species of the B. burgorferi sensu stricto, B. afzelii, B. garinii, to 
avoid the loss of positive samples), more epidemiological studies and analyses of suspected clinical 
cases, to try to determine the true importance of B. burgdorferi infection. 
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